310 related articles for article (PubMed ID: 18255050)
1. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons.
Salum C; Raisman-Vozari R; Michel PP; Gomes MZ; Mitkovski M; Ferrario JE; Ginestet L; Del Bel EA
Brain Res; 2008 Mar; 1198():27-33. PubMed ID: 18255050
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors.
Kiss JP; Zsilla G; Vizi ES
Neurochem Int; 2004 Sep; 45(4):485-9. PubMed ID: 15186914
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes. Relationship to nitric oxide.
Adamczyk A; Kaźmierczak A; Strosznajder JB
Neurochem Int; 2006 Sep; 49(4):407-12. PubMed ID: 16546300
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures.
Sanchez-Ramos J; Facca A; Basit A; Song S
Exp Neurol; 1998 Apr; 150(2):263-71. PubMed ID: 9527896
[TBL] [Abstract][Full Text] [Related]
5. Signaling Mechanisms in the Nitric Oxide Donor- and Amphetamine-Induced Dopamine Release in Mesencephalic Primary Cultured Neurons.
Salum C; Schmidt F; Michel PP; Del-Bel E; Raisman-Vozari R
Neurotox Res; 2016 Jan; 29(1):92-104. PubMed ID: 26391887
[TBL] [Abstract][Full Text] [Related]
6. Catalpol attenuates nitric oxide increase via ERK signaling pathways induced by rotenone in mesencephalic neurons.
Bi J; Jiang B; Hao S; Zhang A; Dong Y; Jiang T; An L
Neurochem Int; 2009; 54(3-4):264-70. PubMed ID: 19111870
[TBL] [Abstract][Full Text] [Related]
7. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.
Gomes MZ; Raisman-Vozari R; Del Bel EA
Brain Res; 2008 Apr; 1203():160-9. PubMed ID: 18313645
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of manganese exposure-induced dopaminergic toxicity.
Prabhakaran K; Ghosh D; Chapman GD; Gunasekar PG
Brain Res Bull; 2008 Jul; 76(4):361-7. PubMed ID: 18502311
[TBL] [Abstract][Full Text] [Related]
9. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures.
Mercer LD; Kelly BL; Horne MK; Beart PM
Biochem Pharmacol; 2005 Jan; 69(2):339-45. PubMed ID: 15627486
[TBL] [Abstract][Full Text] [Related]
10. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
Chipana C; García-Ratés S; Camarasa J; Pubill D; Escubedo E
Neurochem Int; 2008 Feb; 52(3):401-10. PubMed ID: 17716785
[TBL] [Abstract][Full Text] [Related]
11. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
[TBL] [Abstract][Full Text] [Related]
12. Increase in NADPH-diaphorase-positive and neuronal NO synthase immunoreactive neurons in the rat spinal trigeminal nucleus following infusion of a NO donor--evidence for a feed-forward process in NO production involved in trigeminal nociception.
Schlechtweg PM; Röder J; Fischer MJ; Neuhuber W; Messlinger K
Cephalalgia; 2009 May; 29(5):566-79. PubMed ID: 19220305
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
Collo G; Zanetti S; Missale C; Spano P
Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
[TBL] [Abstract][Full Text] [Related]
14. Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction.
Nafia I; Re DB; Masmejean F; Melon C; Kachidian P; Kerkerian-Le Goff L; Nieoullon A; Had-Aissouni L
J Neurochem; 2008 Apr; 105(2):484-96. PubMed ID: 18042178
[TBL] [Abstract][Full Text] [Related]
15. Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures.
Vaglini F; Pardini C; Viaggi C; Caramelli A; Corsini GU
Neuropharmacology; 2008 Oct; 55(5):737-42. PubMed ID: 18634808
[TBL] [Abstract][Full Text] [Related]
16. Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation.
Wersinger C; Chen J; Sidhu A
Mol Cell Neurosci; 2004 Jan; 25(1):124-37. PubMed ID: 14962746
[TBL] [Abstract][Full Text] [Related]
17. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
[TBL] [Abstract][Full Text] [Related]
18. Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons.
Heidenreich BA; Rebec GV
Synapse; 2000 Oct; 38(1):80-6. PubMed ID: 10941143
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures.
Canals S; Casarejos MJ; Rodríguez-Martín E; de Bernardo S; Mena MA
J Neurochem; 2001 Jan; 76(1):56-68. PubMed ID: 11145978
[TBL] [Abstract][Full Text] [Related]
20. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
Ueda S; Sakakibara S; Nakadate K; Noda T; Shinoda M; Joyce JN
Neurosci Lett; 2005 Jun; 380(3):252-6. PubMed ID: 15862896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
